Home
Top Stories
Markets
Market Data
Companies
Opinion
Economy & Policy
Finance
Politics
Technology
Personal Finance
Current Affairs
International
Management
Weekend
General News
Latest News
Today's Paper
Videos
Covid-19
Portfolio
Login
Torrent Pharma
November domestic pharma sales grow just 1% after strong show last month
Torrent Pharma: Cost controls not enough, recovery in key markets crucial
Sensex surges 377 pts as financial, FMCG stocks rally; Nifty ends at 11,889
Torrent Pharma Q2 net up 27% despite dip in US and Brazil revenues
Torrent Pharma Q2 profit up 27% at Rs 310 cr on robust sales, low expenses
Nifty outlook & stock calls by Anand Rathi: Buy TCS, Torrent Pharma
Nifty may resume downtrend if it breaks below 11,350: HDFC Securities
Cipla tweaks management structure to mobilise second level of executives
Torrent Pharma leaps 10%, nears 52-wk high as Q1 net profit jumps 49% YoY
Torrent Pharma Q1 PBT up 44% to Rs 402 cr, income rises marginally
Torrent Pharma slips 6% on profit-booking; outlook remains a concern
Torrent Pharma posts Q4FY20 PBT of Rs 293 cr, consolidated revenue up 4.69%
Market Ahead, May 26: Top factors that could guide markets this week
MSCI India rebalancing to stoke FPI inflows to the tune of Rs 1,900 cr
India growth crucial for Torrent Pharma's health amid steep fall in volume
Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crore
Derivatives strategy on Torrent Pharmaceuticals by HDFC Securities
Subdued Q3 performance leads to stock correction in Torrent Pharma
USFDA red flags Torrent Pharma's US-based arm for manufacturing violations
Top stock picks by CapitalVia: Buy Adani Green Energy, Torrent Pharma
Next